NCT06781385View on ClinicalTrials.gov

Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Stroke

PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 22, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions
Acute Ischemic Stroke
Interventions
DRUG

Intra-arterial Tenecteplase

One-time dose of intra-arterial tenecteplase post-thrombectomy

DRUG

Intra-arterial Saline

One-time dose of intra-arterial saline post-thrombectomy

Trial Locations (1)

28207

Atrium Health Neurosciences Institute, Charlotte

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

Wake Forest University Health Sciences

OTHER

NCT06781385 - Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Stroke | Biotech Hunter | Biotech Hunter